Author: SRI International
-
BioCyc database collection
A comprehensive website for sharing fundamental information about biochemical pathways and genomes with researchers around the world
-
Techneins™ – Non-natural polymers as synthetic affinity reagents and novel therapeutics
SRI Biosciences has developed a molecular discovery platform that enables the synthesis and screening of sequence-defined non-natural polymers, or “Techneins™”, to create potent and selective affinity reagents that can be used as either therapeutics or diagnostic reagents.
-
SynFini™
SRI Biosciences has developed SynFini™, a suite of tools that leverages AI to automate the translation of ideas into testable physical molecules.The SynFini platform helps scientists maximize time spent on what to make, rather than how to make by accelerating chemistry design, developme
-
Telemanipulation in sterile environments for pharmaceutical manufacturing
Pharmaceutical manufacturing environments are highly complex with increasing requirements to minimizing human interaction
-
Ian Colrain talks about SRI Biosciences
Ian Colrain is the former President of SRI’s Biosciences Division in Menlo Park, CA. Join us to learn how SRI Biosciences partners with organizations worldwide to bring new medicines and devices to market through basic research, pharmaceutical and technology discovery, preclinical development and clinical translation. provides services that span all stages of drug and diagnostics…
-
SaTC: EDU: Microlessons to Build Readiness in the Cybersecurity Workforce
We developed a novel microlearning approach and up-to-date curriculum for early- and mid-career cybersecurity professionals that supports anytime, anywhere learning called Cyber Attack!,